Alternatively, TNFI may restore Th1 responses and IFN-γ expression by counteracting the side effects of chronic TNF exposure as described for rheumatoid arthritis (45), ankylosing spondylitis (46) or moderate psoriasis (47). Here, TNF is linked to ankylosing spondylitis.